Trial Profile
Phase II trial of selinexor in combination with low-dose cytarabine in elderly patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs Selinexor (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 14 Oct 2014 New trial record